Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06083051 · ClinicalTrials.gov registry record · NA
Differences in Postoperative Symptoms With Four Ureteral Stents
A NA study of Urinary Stone, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 272
- Enrollment target
- 1
- Study location
NCT06083051: Recruiting NA study of Urinary Stone, sponsored by University of Wisconsin, Madison.
NCT06083051 is a NA study of Urinary Stone that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 272 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06083051, a NA study of Urinary Stone, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 272 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective randomized controlled trial designed to assess the differences in postoperative symptoms related to placement of a 6Fr Percuflex ureteral stents, 6Fr Tria ureteral stents, 4.8Fr Percuflex ureteral stents, and 4.8Fr Tria ureteral stents after ureteroscopy with laser lithotripsy for treatment of upper tract urinary stones. 272 participants will be enrolled and will be on study for up to approximately 10 weeks.
Primary Outcome
USSQ is a 38-item questionnaire to evaluate symptoms and impact on quality of life of ureteral stents. The high scores indicate worse outcomes. It has 5 sections, urinary symptoms, pain, general health, work performance, and sexual matters. The urinary subscale score range from 11-54.
Conditions Studied
Interventions
- DEVICE 6Fr Percuflex ureteral stents
- DEVICE 6Fr Tria ureteral stents
- DEVICE 4.8Fr Tria ureteral stents
- DEVICE 4.8Fr Percuflex ureteral stents
Study Locations (1)
Wisconsin
- University of Wisconsin School of Medicine and Public Health - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2024-03-21 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06083051 shows while recruiting
NCT06083051 is an interventional study that assigns participants to a tested intervention. The registered 272 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Urinary Stone appearing as the primary indexed condition, and to 4 interventions - of which 6Fr Percuflex ureteral stents is the first listed.
NCT06083051 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06083051 about?
NCT06083051 is a clinical study titled "Differences in Postoperative Symptoms With Four Ureteral Stents". This is a prospective randomized controlled trial designed to assess the differences in postoperative symptoms related to placement of a 6Fr Percuflex ureteral stents, 6Fr Tria ureteral stents, 4.8Fr Percuflex ureteral stents, and 4.8Fr Tria ureteral stents after ureteroscopy with laser lithotripsy ...
What is the current status of trial NCT06083051?
This trial is currently recruiting. It is a NA study. The enrollment target is 272 participants. The study started on 2024-03-21. Estimated completion is 2026-12.
What conditions does trial NCT06083051 study?
This clinical trial studies the following conditions: Urinary Stone.
What interventions are being tested in trial NCT06083051?
The interventions under investigation include: 6Fr Percuflex ureteral stents (DEVICE), 6Fr Tria ureteral stents (DEVICE), 4.8Fr Tria ureteral stents (DEVICE), 4.8Fr Percuflex ureteral stents (DEVICE).
Who is sponsoring clinical trial NCT06083051?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06083051 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Stone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06083051's enrollment target sits among peer trials
272 387th of 2000 higher than 1,614 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02468024 · 272 participants · Phase 3
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- NCT05519449 · 272 participants · Phase 1
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- NCT06035939 · 272 participants · NA
SMYLS Multi-site Trial
- NCT06449638 · 272 participants · NA
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI